Answers are grounded in this paper and cite their sources.
Astermark J, Björgell O, Lindén E, Lethagen S, Nilsson P, Berntorp E (University Hospital, Malmö, Sweden). Low recurrence rate after deep calf‐vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med 1998; 244 : 79–82. Objectives To evaluate the recurrence rate after deep calf‐vein thrombosis treated with 6 weeks of oral anticoagulation. Design and subjects A 2 year follow‐up of 126 consecutive patients admitted to the Department of Internal Medicine with venographically verified deep calf‐vein thrombosis. Results One hundred and twenty‐six patients were treated with warfarin for 6 weeks, 18 of them having had a previous episode of venous thrombosis (DVT). Eleven patients (8.7%) suffered a recurrent thromboembolic episode within 2 years, four of which were within the first 3 months. Eight of those without a history of DVT had a recurrence (7.4%). Three of these were activated protein C (APC)‐resistant, one was protein C‐deficient and one had malignant melanoma. Eight patients (6.3%) reported minor haemorrhagic complications, but no major bleeding was seen. Conclusion Our data support the use of a 6 week regimen of secondary oral prophylaxis after a first episode of deep calf‐vein thrombosis in patients without a permanent risk factor. Whether individuals with inherited thrombophilia require prolonged treatment remains to be evaluated.
No takes yet. Share an insight, caveat, or question.
Astermark et al. (1998) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: